Nicolino Ruperto mostly deals with Internal medicine, Surgery, Rheumatology, Arthritis and Juvenile rheumatoid arthritis. Much of his study explores Internal medicine relationship to Physical therapy. His studies deal with areas such as Vasculitis, Polyarteritis nodosa, Clinical trial and Cohort study as well as Surgery.
Nicolino Ruperto has researched Rheumatology in several fields, including Mevalonate kinase deficiency, Rheumatism and Severity of illness. His Arthritis course of study focuses on Placebo and Clinical endpoint. He combines Juvenile rheumatoid arthritis and Juvenile Arthritis Disease Activity Score in his studies.
His primary scientific interests are in Internal medicine, Arthritis, Rheumatology, Physical therapy and Functional ability. As a part of the same scientific family, Nicolino Ruperto mostly works in the field of Internal medicine, focusing on Surgery and, on occasion, Macrophage activation syndrome. The study incorporates disciplines such as Placebo and Tocilizumab, Rheumatoid arthritis, Disease in addition to Arthritis.
His Rheumatology study integrates concerns from other disciplines, such as Etanercept, Pediatrics and Age of onset. His study in the field of Visual analogue scale is also linked to topics like Construct validity. The various areas that Nicolino Ruperto examines in his Functional ability study include Psychometrics and Gerontology.
The scientist’s investigation covers issues in Internal medicine, Arthritis, Rheumatology, Methotrexate and Family medicine. His research on Internal medicine frequently connects to adjacent areas such as Placebo. Nicolino Ruperto has included themes like Discontinuation, Adverse effect, Randomized controlled trial and Cohort in his Arthritis study.
His biological study deals with issues like Quality of life, which deal with fields such as Functional ability. The Rheumatology study combines topics in areas such as Psoriatic arthritis, Rheumatoid arthritis, Oligoarthritis, Orthopedic surgery and Juvenile dermatomyositis. His Methotrexate study integrates concerns from other disciplines, such as Gastroenterology and Prednisone.
Nicolino Ruperto mainly investigates Internal medicine, Arthritis, Rheumatology, Juvenile Arthritis Disease Activity Score and Family medicine. His Methotrexate, Adverse effect, Receiver operating characteristic, Tocilizumab and Complete remission study are his primary interests in Internal medicine. His Arthritis study combines topics from a wide range of disciplines, such as Disease outcome, Pediatric Infectious Disease, Orthopedic surgery, Tuberculosis and Cohort.
The study incorporates disciplines such as MedDRA, Pharmacovigilance, Discontinuation, Consensus conference and Glucocorticoid in addition to Rheumatology. His Family medicine study combines topics in areas such as Clinical trial and Evidence-based medicine. His Clinical study design study in the realm of Clinical trial interacts with subjects such as Stakeholder.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preliminary definition of improvement in juvenile arthritis
Edward H. Giannini;Nicolino Ruperto;Angelo Ravelli;Daniel J. Lovell.
Arthritis & Rheumatism (1997)
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.
Seza Ozen;Angela Pistorio;Silvia M. Iusan;Aysin Bakkaloglu.
Annals of the Rheumatic Diseases (2010)
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides
Seza Ozen;Nicolino Ruperto;Michael Dillon;Arvind Bagga.
Annals of the Rheumatic Diseases (2005)
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Timothy Beukelman;Nivedita M. Patkar;Kenneth G. Saag;Sue Tolleson-Rinehart.
Arthritis Care and Research (2011)
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
Fabrizio De Benedetti;Hermine I. Brunner;Nicolino Ruperto;Andrew Kenwright.
The New England Journal of Medicine (2012)
Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
Daniel J. Lovell;Nicolino Ruperto;Steven Goodman;Andreas Reiff.
The New England Journal of Medicine (2008)
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
Nicolino Ruperto;Hermine I. Brunner;Pierre Quartier;Tamás Constantin.
The New England Journal of Medicine (2012)
Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis
Carol A Wallace;Nicolino Ruperto;Edward Giannini.
The Journal of Rheumatology (2004)
Development and validation of a composite disease activity score for juvenile idiopathic arthritis.
Alessandro Consolaro;Nicolino Ruperto;Anna Bazso;Angela Pistorio.
Arthritis & Rheumatism (2009)
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
Nicolino Ruperto;Daniel J Lovell;Pierre Quartier;Eliana Paz.
The Lancet (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: